Literature DB >> 1808803

Autosomal dominant retinitis pigmentosa with rhodopsin, valine-345-methionine.

E L Berson1, M A Sandberg, T P Dryja.   

Abstract

Rhodopsin gene mutations appear to cause some forms of autosomal dominant retinitis pigmentosa. In the family described, the mutation called rhodopsin, Val345Met segregated perfectly with the disease. All affected individuals had abnormal ERGs; the two oldest members of this family had more loss of function than the two youngest members. Some intra-familial variability existed as an older member showed larger visual fields and ERG amplitudes than a younger member. This mutation was not seen in 106 control subjects nor in any other patients yet described with other rhodopsin gene mutations. Patients so far studied with rhodopsin, Val345Met, have smaller 0.5-Hz full-field ERG amplitudes, on average, than those with Pro23His or Thr58Arg and larger ERG amplitudes than those with Pro347Leu or Pro347Ser. These forms of retinitis pigmentosa can now be detected through analysis of leukocyte DNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1808803      PMCID: PMC1298619     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  22 in total

1.  Turnover of total carbon dioxide in the aqueous humors and the effect thereon of acetazolamide.

Authors:  V E KINSEY; D V REDDY
Journal:  AMA Arch Ophthalmol       Date:  1959-07

2.  Multipoint linkage analysis and heterogeneity testing in 20 X-linked retinitis pigmentosa families.

Authors:  M A Musarella; L Anson-Cartwright; S M Leal; L D Gilbert; R G Worton; G A Fishman; J Ott
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

3.  Transepithelial electrical measurements on the isolated rabbit iris-ciliary body.

Authors:  T Krupin; P S Reinach; O A Candia; S M Podos
Journal:  Exp Eye Res       Date:  1984-02       Impact factor: 3.467

4.  Rhodopsin mutants that bind but fail to activate transducin.

Authors:  R R Franke; B König; T P Sakmar; H G Khorana; K P Hofmann
Journal:  Science       Date:  1990-10-05       Impact factor: 47.728

Review 5.  Ocular findings in a form of retinitis pigmentosa with a rhodopsin gene defect.

Authors:  E L Berson
Journal:  Trans Am Ophthalmol Soc       Date:  1990

6.  Ocular findings in patients with autosomal dominant retinitis pigmentosa and rhodopsin, proline-347-leucine.

Authors:  E L Berson; B Rosner; M A Sandberg; C Weigel-DiFranco; T P Dryja
Journal:  Am J Ophthalmol       Date:  1991-05-15       Impact factor: 5.258

7.  Autosomal dominant sectoral retinitis pigmentosa. Two families with transversion mutation in codon 23 of rhodopsin.

Authors:  J R Heckenlively; J A Rodriguez; S P Daiger
Journal:  Arch Ophthalmol       Date:  1991-01

8.  Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His).

Authors:  E L Berson; B Rosner; M A Sandberg; T P Dryja
Journal:  Arch Ophthalmol       Date:  1991-01

9.  A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa.

Authors:  C F Inglehearn; R Bashir; D H Lester; M Jay; A C Bird; S S Bhattacharya
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

View more
  3 in total

1.  Regulation of sorting and post-Golgi trafficking of rhodopsin by its C-terminal sequence QVS(A)PA.

Authors:  D Deretic; S Schmerl; P A Hargrave; A Arendt; J H McDowell
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 2.  Finding and interpreting genetic variations that are important to ophthalmologists.

Authors:  Edwin M Stone
Journal:  Trans Am Ophthalmol Soc       Date:  2003

3.  Early structural anomalies observed by high-resolution imaging in two related cases of autosomal-dominant retinitis pigmentosa.

Authors:  Sung Pyo Park; Winston Lee; Eun Jin Bae; Vivianne Greenstein; Bum Ho Sin; Stanley Chang; Stephen H Tsang
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2014 Sep-Oct       Impact factor: 1.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.